NCT00366431

Brief Summary

The primary purpose of the protocol is to evaluate the safety, efficacy, and tolerability of MOA-728 in subjects with Opioid-Induced Bowel Dysfunction (OIBD) with associated chronic non-malignant pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
420

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Aug 2006

Shorter than P25 for phase_2

Geographic Reach
1 country

67 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2006

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

August 18, 2006

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 21, 2006

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2007

Completed
Last Updated

November 25, 2019

Status Verified

November 1, 2019

First QC Date

August 18, 2006

Last Update Submit

November 21, 2019

Conditions

Keywords

OIBDOICOpioidConstipationLaxative

Outcome Measures

Primary Outcomes (1)

  • The effect of the interventional treatment will be measured by the change from baseline in the number of bowel movements per week during the double-blind treatment period.

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult outpatients with opioid-induced bowel dysfunction and chronic non-malignant pain.
  • Taking oral, transdermal, intravenous, or subcutaneous opioids.
  • Willingness to discontinue all pre-study laxative therapy and utilize only study permitted rescue laxatives.

You may not qualify if:

  • History of chronic constipation before the initiation of opioid therapy.
  • Other GI disorders known to affect bowel transit.
  • Women who are pregnant, breast-feeding, or plan to become pregnant.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (67)

Unknown Facility

Birmingham, Alabama, 35215, United States

Location

Unknown Facility

Birmingham, Alabama, 35244, United States

Location

Unknown Facility

Mobile, Alabama, 36608, United States

Location

Unknown Facility

Phoenix, Arizona, 85029, United States

Location

Unknown Facility

Tucson, Arizona, 85710, United States

Location

Unknown Facility

Tucson, Arizona, 85712, United States

Location

Unknown Facility

Tucson, Arizona, 85741, United States

Location

Unknown Facility

Hot Springs, Arkansas, 71913, United States

Location

Unknown Facility

Anaheim, California, 92801, United States

Location

Unknown Facility

Anaheim, California, 92805, United States

Location

Unknown Facility

Bakersfield, California, 93311, United States

Location

Unknown Facility

Foothill Ranch, California, 92610, United States

Location

Unknown Facility

Garden Grove, California, 92843, United States

Location

Unknown Facility

Los Gatos, California, 95032, United States

Location

Unknown Facility

Orange, California, 92869, United States

Location

Unknown Facility

Sacramento, California, 95831, United States

Location

Unknown Facility

San Diego, California, 92108, United States

Location

Unknown Facility

San Diego, California, 92120, United States

Location

Unknown Facility

San Diego, California, 92121, United States

Location

Unknown Facility

Trumbull, Connecticut, 06611, United States

Location

Unknown Facility

Hollywood, Florida, 33021, United States

Location

Unknown Facility

Jacksonville, Florida, 32216, United States

Location

Unknown Facility

Jupiter, Florida, 33458, United States

Location

Unknown Facility

Largo, Florida, 33770, United States

Location

Unknown Facility

Miami, Florida, 33173, United States

Location

Unknown Facility

Miami, Florida, 33180, United States

Location

Unknown Facility

Ocala, Florida, 34471, United States

Location

Unknown Facility

Ormond Beach, Florida, 32174, United States

Location

Unknown Facility

Saint Cloud, Florida, 34769, United States

Location

Unknown Facility

Tampa, Florida, 33607, United States

Location

Unknown Facility

West Palm Beach, Florida, 33401, United States

Location

Unknown Facility

Dawsonville, Georgia, 30534, United States

Location

Unknown Facility

Marietta, Georgia, 30060, United States

Location

Unknown Facility

Marietta, Georgia, 30066, United States

Location

Unknown Facility

Bloomington, Illinois, 61701, United States

Location

Unknown Facility

Chicago, Illinois, 60610, United States

Location

Unknown Facility

Indianapolis, Indiana, 46250, United States

Location

Unknown Facility

Elkridge, Maryland, 21075, United States

Location

Unknown Facility

Boston, Massachusetts, 02115, United States

Location

Unknown Facility

Brockton, Massachusetts, 02301, United States

Location

Unknown Facility

Saginaw, Michigan, 48602, United States

Location

Unknown Facility

Traverse City, Michigan, 49684, United States

Location

Unknown Facility

Picayune, Mississippi, 39466, United States

Location

Unknown Facility

Independence, Missouri, 64055, United States

Location

Unknown Facility

Missoula, Montana, 59808, United States

Location

Unknown Facility

Omaha, Nebraska, 68114, United States

Location

Unknown Facility

Reno, Nevada, 89502, United States

Location

Unknown Facility

Haddon Heights, New Jersey, 08035, United States

Location

Unknown Facility

Albuquerque, New Mexico, 87102, United States

Location

Unknown Facility

Great Neck, New York, 11023, United States

Location

Unknown Facility

Lake Success, New York, 11042, United States

Location

Unknown Facility

Charlotte, North Carolina, 28210, United States

Location

Unknown Facility

Winston-Salem, North Carolina, 27103, United States

Location

Unknown Facility

Cincinnati, Ohio, 45219, United States

Location

Unknown Facility

Cincinnati, Ohio, 45224, United States

Location

Unknown Facility

Dayton, Ohio, 45439, United States

Location

Unknown Facility

Clinton, Oklahoma, 73601, United States

Location

Unknown Facility

Chattanooga, Tennessee, 37404, United States

Location

Unknown Facility

Beaumont, Texas, 77701, United States

Location

Unknown Facility

Colleyville, Texas, 76034, United States

Location

Unknown Facility

San Antonio, Texas, 78205, United States

Location

Unknown Facility

San Antonio, Texas, 78209, United States

Location

Unknown Facility

San Antonio, Texas, 78238, United States

Location

Unknown Facility

Alexandria, Virginia, 22304, United States

Location

Unknown Facility

Christiansburg, Virginia, 24073, United States

Location

Unknown Facility

Norfolk, Virginia, 23502, United States

Location

Unknown Facility

Richmond, Virginia, 23229, United States

Location

MeSH Terms

Conditions

Constipation

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jeff Cohn

    Bausch Health Americas, Inc.

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

August 18, 2006

First Posted

August 21, 2006

Study Start

August 1, 2006

Study Completion

March 1, 2007

Last Updated

November 25, 2019

Record last verified: 2019-11

Locations